Funder: National Key R and D Program of China(2019YFA0709501,2018YFC1312900) The Shanghai Pujiang Project(18PJ1400900)Funder: Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1); NIH Consortium grant U54 EB020403; the cross-NIH alliance thatfunds Big Data to Knowledge Centres of Excellence (ENIGMA, GrantNos. 5U54EB020403-05 and 1R56AG058854-01Funder: the Eranet Neuron (AF12-NEUR0008-01 – WM2NA ; and ANR-18-NEUR00002-01 – ADORe);Paris Sud University IDEX 2012;Fédération pour la Recherche sur le Cerveau;Funder: Assistance Publique - Hôpitaux de Paris (Assistance Publique Hôpitaux de Paris); doi: https://doi.org/10.13039/501100002738Funder: Fondation de l'Avenir pour la Recherche Médicale Appliquée (Fondation de l'Avenir); doi: https://doi.org/10.13039/100007380Funder: the ANR (ANR-12-SAMA-0004）；INSERM (interface grant)Funder: DH | National Institute for Health Research (NIHR); doi: https://doi.org/10.13039/501100000272Funder: South London and Maudsley NHS Foundation Trust; doi: https://doi.org/10.13039/100009362Funder: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology) (LSHM-CT- 2007-037286);the Horizon 2020-funded ERC Advanced Grant' STRATIFY' (Brain network based stratification of reinforcement-related disorders) (695313);ERANID (Understanding the Interplay between Cultural, Biological and Subjective Factors in Drug Use Pathways) (PR-ST-0416-10004);Human Brain Project (HBP SGA 2, 785907, and HBP SGA 3, 945539);the Medical Research Council Grant' c-VEDA' (Consortium on Vulnerability to Externalising Disorders and Addictions) (MR/N000390/1) ;Forschungsnetz AERIAL 01EE1406A, 01EE1406B)Funder: Guangdong Key Research and Development Project(No. 2018B030335001);the 111 Project (B18015);the key project of Shanghai Science and Technology (16JC1420402)
